SCHEMBL30870314

SCHEMBL30870314

O=C1C=Cc2c(c3c(=O)c(=O)c(=O)c(=O)c3c3ccccc23)C1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CES1 P23141 2/20 0.43
▸ IDO1 P14902 2/20 0.34
▸ MEN1 O00255 2/20 0.34
▸ ALDH1A1 P00352 2/20 0.34
▸ LMNA P02545 2/20 0.34
▸ HPGD P15428 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ BCHE P06276 1/20 0.34
▸ POLB P06746 1/20 0.34
▸ PTPRC P08575 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ THRB P10828 1/20 0.34
▸ PKM P14618 1/20 0.34
▸ ALOX15 P16050 1/20 0.34
▸ PTPN1 P18031 1/20 0.34
▸ ACHE P22303 1/20 0.34
▸ RECQL P46063 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ PTPN22 Q9Y2R2 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11793572 0.78 CES1 (0.50) CES1IDO1MEN1ALDH1A1LMNA
SCHEMBL30288157 0.78 CES1 (0.50) CES1IDO1MEN1ALDH1A1LMNA
SCHEMBL30362942 0.72 ALDH1A1 (0.46) MEN1ALDH1A1LMNAHPGDKMT2A
SCHEMBL30843875 0.72 CES1 (0.44) CES1IDO1MEN1ALDH1A1LMNA
SCHEMBL29250726 0.72 CES1 (0.44) CES1IDO1MEN1ALDH1A1LMNA
SCHEMBL17699232 0.70 CES1 (0.51) CES1MEN1ALDH1A1LMNAHPGD
SCHEMBL10941056 0.69 CES1 (0.50) CES1IDO1MEN1ALDH1A1LMNA
SCHEMBL28356949 0.66 CES1 (0.32) CES1IDO1MEN1ALDH1A1LMNA
SCHEMBL31506632 0.64 CES1 (0.49) CES1IDO1MEN1ALDH1A1LMNA
SCHEMBL20669045 0.62 S100A4 (0.48) ALDH1A1LMNAHPGDKDM4EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12583863-B2 Synthetically modifiable ion channels UNIVERSITY OF WYOMING (US) 2026-03-24 — — US disclosed
US-20240300967-A1 SYNTHETICALLY MODIFIABLE ION CHANNELS UNIVERSITY OF WYOMING 2024-09-12 — — US disclosed
US-11976078-B2 Synthetically modifiable ion channels UNIVERSITY OF WYOMING (US) 2024-05-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240300967-A1 SYNTHETICALLY MODIFIABLE ION CHANNELS KCNN2, KCNN1, HCN4 CES1 4866/4885IDO1 2828/4885MEN1 543/4885
US-12583863-B2 Synthetically modifiable ion channels HCN4, HCN3, HCN2 CES1 4767/4885IDO1 3348/4885MEN1 1357/4885
US-11976078-B2 Synthetically modifiable ion channels KCNN2, KCNN1, HCN4 CES1 4866/4885IDO1 2828/4885MEN1 543/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback